Centene Corporation (CNC)
Best Growth Stocks to Buy for May 26th
CNC, SANM and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 26, 2026.
Has Centene (CNC) Outpaced Other Medical Stocks This Year?
Here is how Centene (CNC) and Cellectar Biosciences, Inc. (CLRB) have performed compared to their sector so far this year.
Best Growth Stocks to Buy for May 7th
CNC, WOOF and VLO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 7, 2026.
Best Value Stocks to Buy for May 7th
CNC, SLDE and UVE made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 7, 2026.
New Strong Buy Stocks for May 7th
CSTM, CNC, TEAM, WDC and COLM have been added to the Zacks Rank #1 (Strong Buy) List on May 7, 2026.
Here's Why Centene (CNC) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how
Don Lair writes about options income, dividend strategy, and the kind of boring-but-durable investing that actually funds retirement.
Centene: Further Upside Will Require Better Execution
Centene rebounded in Q1-2026 with a significant improvement in its health benefits ratio, dropping to 87.3% from 94.3% in Q4-2025. CNC's Medicaid HBR improvement was driven by rate increases, medical cost management, and a mild flu season, though management remains cautious on sustainability. Despite a strong Q1-2026 beat, CNC raised full-year guidance less than the quarterly outperformance, reflecting uncertainty about trend continuation.
Centene: Big Comeback Story
Centene Corporation delivered a strong Q1 earnings beat, signaling a robust turnaround after a challenging year for health insurers. Q1 revenue surged to $49.94 billion, up 7.1% year-over-year and $2.4 billion above consensus, driven by premium yield and Medicaid growth. Cost discipline was evident as the health benefits ratio fell to 87.3% and SG&A expenses declined, fueling a $1.24 adjusted EPS beat versus consensus.
Centene stock rises as earnings beat, outlook lifted on cost cuts
Shares of Centene Corporation rose about 14% on Tuesday after the company reported stronger-than-expected first-quarter results, driven by cost controls and steady premium growth. The St. Louis-based managed-care company posted net earnings of $1.54 billion, or $3.11 per share, up from $1.31 billion, or $2.63 per share, a year earlier.
Centene Q1 Earnings Beat Estimates on Rising Premiums, 2026 View Up
CNC tops Q1 estimates on strong premiums, lifts 2026 outlook with higher revenue and EPS guidance despite membership decline and rising costs.
Centene Corporation (CNC) Q1 2026 Earnings Call Transcript
Centene Corporation (CNC) Q1 2026 Earnings Call Transcript
